Global Parkinson’s Genetics Program GP2 in Australia

Published on: 20 March 2026

Genetics is transforming our understanding of Parkinson’s. By identifying the genes and biological pathways involved, researchers are moving closer to earlier detection, personalised treatment approaches, and ultimately disease-modifying therapies.

In this session, we will:

-  Explain why genetics research is so important in Parkinson’s disease

-  Introduce our new Tasmania-based blood collection project for genetic analysis -  Outline how you can get involved

-  Show how this work connects to the Global Parkinson’s Genetics Program (GP2) — a worldwide consortium accelerating discovery through large-scale collaboration.

While blood collection for this project is currently taking place in Tasmania, the data contributes to GP2, a major international initiative analysing genetic information from diverse populations across the globe. By participating locally, Tasmanians are helping power discoveries with worldwide impact. We will also briefly share how this genetics work complements our ongoing research into isolated REM Sleep Behaviour Disorder (iRBD), a key early indicator of Parkinson’s that offers important insight into risk and disease progression.

You can learn more about the international research study here: Global Parkinson’s Genetics Program (GP2): https://gp2.org


Back to News